We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.8B
AUM Growth
-$180M
Cap. Flow
-$262M
Cap. Flow %
-6.89%
Top 10 Hldgs %
17.53%
Holding
781
New
342
Increased
77
Reduced
104
Closed
239

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$71.1M
2
ARMK icon
Aramark
ARMK
+$57.7M
3
BA icon
Boeing
BA
+$46.8M
4
EBAY icon
eBay
EBAY
+$46.2M
5
ITGR icon
Integer Holdings
ITGR
+$41.2M

Sector Composition

Rank Sector Weight
1 Industrials 14.07%
2 Consumer Discretionary 12.1%
3 Technology 10.49%
4 Healthcare 7.89%
5 Financials 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECHO
176
EchoStar
ECHO
$24.4B
$5.57M 0.15%
51,260
-285,048
-85% -$23.2M
ORCL icon
177
Oracle
ORCL
$374B
$5.57M 0.15%
+28,567
New +$6.8M
TRVI icon
178
Trevi Therapeutics
TRVI
$2.59B
$5.56M 0.15%
444,357
-348,449
-44% -$4.03M
KWEB icon
179
CALL
KraneShares CSI China Internet ETF
KWEB
$5.64B
$5.45M 0.14%
+160,000
New +$6.15M
SNDA icon
180
Sonida Senior Living
SNDA
$1.91B
$5.43M 0.14%
+166,500
New +$4.94M
CSCO icon
181
PUT
Cisco
CSCO
$457B
$5.39M 0.14%
+70,000
New +$5.19M
GENI icon
182
CALL
Genius Sports
GENI
$1.85B
$5.36M 0.14%
486,100
+225,300
+86% +$2.46M
IONS icon
183
Ionis Pharmaceuticals
IONS
$8.6B
$5.35M 0.14%
67,639
-28,559
-30% -$2.15M
RHLD
184
Resolute Holdings Management
RHLD
$1.02B
$5.32M 0.14%
+25,794
New +$3.82M
AMZN icon
185
CALL
Amazon
AMZN
$2.92T
$5.31M 0.14%
23,000
-78,000
-77% -$17.8M
GDOT icon
186
Green Dot
GDOT
$743M
$5.27M 0.14%
+411,107
New +$5.11M
CEPF
187
Cantor Equity Partners IV
CEPF
$595M
$5.22M 0.14%
507,909
+407,909
+408% +$4.24M
PRMB
188
CALL
Primo Brands
PRMB
$8.24B
$5.22M 0.14%
+319,200
New +$5.9M
IHI icon
189
iShares US Medical Devices ETF
IHI
$3.13B
$5.22M 0.14%
83,942
+10,604
+14% +$655K
HUBS icon
190
HubSpot
HUBS
$12.2B
$5.2M 0.14%
+12,970
New +$5.37M
DMAA
191
Drugs Made In America Acquisition Corp
DMAA
$260M
$5.19M 0.14%
500,000
FCRS
192
FutureCrest Acquisition Corp
FCRS
$368M
$5.14M 0.14%
+508,850
New +$5.15M
GAP
193
CALL
The Gap Inc
GAP
$7.23B
$5.12M 0.13%
200,100
-189,900
-49% -$4.6M
KNX icon
194
Knight Transportation
KNX
$11.3B
$5.05M 0.13%
+96,631
New +$4.53M
ARGX icon
195
CALL
argenx
ARGX
$53.4B
$5.05M 0.13%
6,000
+3,100
+107% +$2.65M
SLVM icon
196
Sylvamo
SLVM
$1.49B
$5.04M 0.13%
+104,708
New +$4.77M
ANNX icon
197
Annexon
ANNX
$834M
$4.99M 0.13%
993,795
-113,206
-10% -$433K
UNH icon
198
CALL
UnitedHealth
UNH
$376B
$4.95M 0.13%
+15,000
New +$5.08M
GILD icon
199
PUT
Gilead Sciences
GILD
$162B
$4.91M 0.13%
40,000
REGN icon
200
Regeneron Pharmaceuticals
REGN
$78.5B
$4.9M 0.13%
6,352
-14,914
-70% -$10.1M

Similar funds

J. Goldman & Co's Q4 2025 Portfolio in Review

As of Q4 2025, J. Goldman & Co held 781 positions worth $3.8B, down 4.5% from $3.98B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

J. Goldman & Co withdrew a net $262M in Q4 2025, closing 239 positions and reducing 104 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $74.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, J. Goldman & Co opened a new position in Honeywell worth $70.9M.

  • J. Goldman & Co's largest Q4 2025 buy was Honeywell: 363,411 shares worth $70.9M.
  • J. Goldman & Co added most to eBay in Q4 2025, an estimated $46.2M increase.
  • J. Goldman & Co's biggest Q4 2025 reduction was Globus Medical, cutting an estimated $61.8M.
  • J. Goldman & Co fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $74.4M.
  • J. Goldman & Co's ten largest holdings make up 18% of its $3.8B portfolio in Q4 2025.
  • J. Goldman & Co opened 342 new positions and closed 239 in Q4 2025.
  • J. Goldman & Co's portfolio value fell 4.5% quarter-over-quarter to $3.8B.

Based on J. Goldman & Co's 13F filing for Q4 2025, filed 17 Feb 2026.